Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 4—April 2020
Research Letter

Knowledge of Infectious Disease Specialists Regarding Aspergillosis Complicating Influenza, United States

Mitsuru TodaComments to Author , Susan E. Beekmann, Philip M. Polgreen, Tom M. Chiller, Brendan R. Jackson, and Karlyn D. Beer
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Toda, T.M. Chiller, B.R. Jackson, K.D. Beer); University of Iowa, Iowa City, Iowa, USA (S.E. Beekmann, P.M. Polgreen)

Main Article


Summary results of survey on invasive pulmonary aspergillosis accompanying severe influenza among a network of infectious disease specialists, United States, May–June, 2018*

Survey characteristic No. (%)
Region where respondents are from, n = 114
Midwest 25 (22)
Northeast 27 (24)
South 33 (29)
29 (25)
Familiar with reports of aspergillosis after severe influenza infection, n = 114
Yes, familiar with reports 29 (26)
No, not familiar with reports
83 (73)
Seen or heard about a case of aspergillosis in the setting of severe influenza at place of work, n = 114
Yes, 1 case 15 (13)
Yes, >2 cases 6 (5)
93 (82)
For patients with influenza requiring ICU admission, how commonly are lower respiratory specimens (e.g., bronchoalveolar lavage, bronchial wash) obtained, n = 108
Never 2 (2)
Rarely 28 (26)
Sometimes 45 (42)
Very often 28 (26)
5 (5)
When treating patients with severe influenza in the ICU and worsening respiratory function, how often do you order galactomannan testing (e.g., in serum or bronchoalveolar lavage), n = 107
Never 30 (28)
Rarely 45 (42)
Sometimes 24 (22)
Very often 4 (4)
Always 4 (4)

*n values indicate number of participants who responded. ICU, intensive care unit.

Main Article

Page created: March 17, 2020
Page updated: March 17, 2020
Page reviewed: March 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.